Medical technology company Olympus has introduced its next-generation EVIS X1 endoscopy system for gastrointestinal (GI) practitioners.

Earlier this year, the company received approval for this endoscopy system, along with GIF-1100 and CF-HQ1100DL/I compatible endoscopes.

The GIF-1100 gastrointestinal videoscope is intended for use within the upper digestive tract while the CF-HQ1100DL/I colonovideoscope is designated to be used within the lower digestive tract.

The EVIS X1 endoscopy system features Texture and Color Enhancement Imaging technology to enhance image colour and texture during endoscopic screening to increase the visibility of lesions and polyps.

It also utilises red dichromatic imaging (RDI) technology to increase the visibility of deep blood vessels and bleeding points.

The system deploys brightness adjustment imaging with maintenance of contrast technology for correcting the brightness levels in dark areas of the endoscopic image and maintaining the brightness of lighter areas to enhance the total distance view.

EVIS X1 also incorporates narrow-band imaging technology to increase the visual observation of mucosal and vascular patterns by using specific green and blue wavelengths absorbed by haemoglobin.

Olympus America Medical Systems Group president Richard Reynolds said: “Olympus is thrilled to bring our most advanced endoscopy system to GI practitioners in the US.

“The remarkable new technologies for visualising the GI tract are designed to help physicians see more and do more to help their patients.”

The company will exhibit the new endoscopy system at the American College of Gastroenterology annual meeting in Vancouver, Canada. This event will take place between 22 and 24 October this year.

Olympus GI endoscopy systems are intended for the diagnosing, treating and observing of diseases and disorders of the upper and lower GI tract, including Crohn's disease, Celiac disease, acid reflux, ulcers and colorectal cancer.